In a world of COVID-19 data, we deliver COVID-19 insights.
BlueDot empowers responses to infectious disease risk using human and artificial intelligence.
Ahead of the curve throughout the pandemic:
BlueDot was among the first in the world to identify the emerging risk from COVID-19 in Hubei province and notify our clients via our Insights platform.
BlueDot published the first scientific paper on COVID-19, accurately predicting eight of the first ten cities to import the novel coronavirus.
BlueDot’s COVID Data Suite delivers bespoke, near-real-time intelligence to governments, hospitals and airlines, revealing COVID-19’s movements.
BlueDot’s regular Focus Reports identified India and Brazil as future epicentres months before case counts in those regions began to climb.
A track record of accurately assessing outbreak risk:
2013 BlueDot founded – Our mission: To create a global early warning system for infectious disease.
2014 Ebola – Accurately identified importation risks from outbreak in West Africa.
2016 Zika – Predicted spread of Zika virus to Florida six months before official reports.
2019 Covid-19 – Identified undiagnosed pneumonia in Wuhan on December 31.
Timely. Tailored. Trustworthy.
BlueDot for Business
We empower enterprise to manage global supply chains, protect mobile workforces, ensure continuity, and build outbreak resilience.
BlueDot Insights – Our cloud platform delivers tailored outbreak risk awareness in near real-time.
COVID Data Suite – Accessible within BlueDot Insights, this is our hub for the latest intelligence about COVID-19, including sub-national data and epidemic curves.
COVID Focus Reports – Also for BlueDot Insights subscribers, these reports deliver curated research on COVID-19 that examines where the pandemic is heading.
BlueDot Explorer – Our geographic information system combines over 100 datasets to help advanced users quickly perform complex risk assessments.
Your Advantage with BlueDot: No other service can match our mission, technology, and track record.
When it comes to infectious disease, timing is everything. BlueDot Insights identified the COVID-19 outbreak in Wuhan on December 31, 2019, sending an alert six days before the U.S. Centers for Disease Control and Prevention and nine days before the World Health Organization.
Infectious disease risk is not one-size-fits-all. Our platform provides the specific information and intelligence you need to ensure you don’t over or under respond to an infectious disease threat.
From Ebola to Zika, BlueDot has a proven record of anticipating outbreak risk. In January 2020, we published the very first scientific paper on COVID-19, accurately identifying 8 of the top 10 cities that would import the novel coronavirus.